KHIRON LIFE SCIENCES CORP (KHRN.CA) Stock Fundamental Analysis
Canada • TSX Venture Exchange • TSX-V:KHRN • CA49374L3065
0.04 CAD
0 (0%)
Last: May 5, 2023, 07:00 PM
Overall KHRN gets a fundamental rating of 2 out of 10. We evaluated KHRN against 34 industry peers in the Pharmaceuticals industry. KHRN may be in some trouble as it scores bad on both profitability and health. KHRN shows excellent growth, but is valued quite expensive already.
1. Profitability
1.1 Basic Checks
- In the past year KHRN has reported negative net income.
- In the past year KHRN has reported a negative cash flow from operations.
1.2 Ratios
- KHRN has negative profitability rations, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- KHRN has a Gross Margin (19.51%) which is comparable to the rest of the industry.
- In the last couple of years the Gross Margin of KHRN has declined.
- The Profit Margin and Operating Margin are not available for KHRN so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 19.51% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.81%
GM growth 5YN/A
2. Health
2.1 Basic Checks
- KHRN does not have a ROIC to compare to the WACC, probably because it is not profitable.
- KHRN has more shares outstanding than it did 1 year ago.
- The debt/assets ratio for KHRN is higher compared to a year ago.
2.2 Solvency
- Based on the Altman-Z score of -5.28, we must say that KHRN is in the distress zone and has some risk of bankruptcy.
- The Altman-Z score of KHRN (-5.28) is worse than 70.45% of its industry peers.
- KHRN has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
- KHRN has a better Debt to Equity ratio (0.05) than 68.18% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.05 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -5.28 |
ROIC/WACCN/A
WACC6.71%
2.3 Liquidity
- KHRN has a Current Ratio of 1.91. This is a normal value and indicates that KHRN is financially healthy and should not expect problems in meeting its short term obligations.
- KHRN has a Current ratio of 1.91. This is comparable to the rest of the industry: KHRN outperforms 59.09% of its industry peers.
- KHRN has a Quick Ratio of 1.91. This is a bad value and indicates that KHRN is not financially healthy enough and could expect problems in meeting its short term obligations.
- The Quick ratio of KHRN (0.91) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.91 | ||
| Quick Ratio | 0.91 |
3. Growth
3.1 Past
- The earnings per share for KHRN have decreased strongly by -59.04% in the last year.
- KHRN shows a strong growth in Revenue. In the last year, the Revenue has grown by 38.20%.
- Measured over the past years, KHRN shows a very strong growth in Revenue. The Revenue has been growing by 143.00% on average per year.
EPS 1Y (TTM)-59.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%11.56%
Revenue 1Y (TTM)38.2%
Revenue growth 3Y143%
Revenue growth 5YN/A
Sales Q2Q%-3.82%
3.2 Future
- Based on estimates for the next years, KHRN will show a very strong growth in Earnings Per Share. The EPS will grow by 25.99% on average per year.
- KHRN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 40.15% yearly.
EPS Next Y39.13%
EPS Next 2Y31.88%
EPS Next 3Y25.99%
EPS Next 5YN/A
Revenue Next Year36.43%
Revenue Next 2Y38.09%
Revenue Next 3Y45.7%
Revenue Next 5Y40.15%
3.3 Evolution
- The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
- KHRN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for KHRN. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as KHRN's earnings are expected to grow with 25.99% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.88%
EPS Next 3Y25.99%
5. Dividend
5.1 Amount
- No dividends for KHRN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
KHIRON LIFE SCIENCES CORP / KHRN.CA FAQ
What is the ChartMill fundamental rating of KHIRON LIFE SCIENCES CORP (KHRN.CA) stock?
ChartMill assigns a fundamental rating of 2 / 10 to KHRN.CA.
Can you provide the valuation status for KHIRON LIFE SCIENCES CORP?
ChartMill assigns a valuation rating of 3 / 10 to KHIRON LIFE SCIENCES CORP (KHRN.CA). This can be considered as Overvalued.
Can you provide the profitability details for KHIRON LIFE SCIENCES CORP?
KHIRON LIFE SCIENCES CORP (KHRN.CA) has a profitability rating of 0 / 10.
What is the financial health of KHIRON LIFE SCIENCES CORP (KHRN.CA) stock?
The financial health rating of KHIRON LIFE SCIENCES CORP (KHRN.CA) is 1 / 10.
What is the expected EPS growth for KHIRON LIFE SCIENCES CORP (KHRN.CA) stock?
The Earnings per Share (EPS) of KHIRON LIFE SCIENCES CORP (KHRN.CA) is expected to grow by 39.13% in the next year.